Cargando…
CRISPR-Cas9-Mediated Genome Editing Increases Lifespan and Improves Motor Deficits in a Huntington’s Disease Mouse Model
Huntington’s disease (HD) is a currently incurable and, ultimately, fatal neurodegenerative disorder caused by a CAG trinucleotide repeat expansion within exon 1 of the huntingtin (HTT) gene, which results in the production of a mutant protein that forms inclusions and selectively destroys neurons i...
Autores principales: | Ekman, Freja K., Ojala, David S., Adil, Maroof M., Lopez, Paola A., Schaffer, David V., Gaj, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717077/ https://www.ncbi.nlm.nih.gov/pubmed/31465962 http://dx.doi.org/10.1016/j.omtn.2019.07.009 |
Ejemplares similares
-
In vivo genome editing improves motor function and extends survival in a mouse model of ALS
por: Gaj, Thomas, et al.
Publicado: (2017) -
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
por: Gaj, Thomas, et al.
Publicado: (2017) -
hPSC-Derived Striatal Cells Generated Using a Scalable 3D Hydrogel Promote Recovery in a Huntington Disease Mouse Model
por: Adil, Maroof M., et al.
Publicado: (2018) -
CRISPR/Cas9 Mediated Therapeutic Approach in Huntington’s Disease
por: Alkanli, Suleyman Serdar, et al.
Publicado: (2022) -
CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020)